Articles

States take up stem cell debate

Minnesota, Oklahoma legislators seek to criminalize some embryonic stem cell research procedures
Written byAmy Swinderman
| 3 min read

ST. PAUL, Minn. and OKLAHOMA CITY, Okla.—As a nationaldebate rages over President Barack Obama's policy to make federal fundsavailable for stem cell research—with a handful of contentious lawsuits makingtheir way through federal courts—states are now taking up the issue, with twostate legislatures close to passing laws that will make certain human embryonicstem cell (hESC) research procedures a criminal act.

At press time, the state legislatures of Minnesota andOklahoma were both in the process of passing such legislation, spurred by thepresident's 2009 executive order to lift federal funding restrictions onembryonic stem cell research placed in August 2001 by former President GeorgeW. Bush. Several federal lawsuits are seeking to not only reverse Obama's OK ofmaking federal funds available to those engaged in hESC research, but to ban certainaspects of this type of research altogether.

Now states are exercising their rights to oppose the federalpolicy and take that opposition a step further by making certain hESC researchprocedures a criminal act.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of a single cell surrounded by small molecular particles in a red biological environment.
Measuring mRNA and protein together at single cell resolution can uncover tumor-specific signaling activity and immune features.
Illustration of an antibody intertwined with a DNA double helix.
Discover how CRISPR and single-cell RNA sequencing can connect disease-associated variants to regulatory elements, genes, and pathways.
Digital illustration of the human digestive system highlighting the liver, stomach, and intestines.
Explore how human gut-liver models can improve the translation of preclinical findings into clinical pharmacokinetic predictions.